Tufts Launchpad | BioLabs

Our mission is to support and accelerate the growth & success of early-stage life science #startups, promoting entrepreneurial #biotech innovation in Boston.

[Tufts Launchpad | BioLabs @BioLabsBoston]

Are you a #lifescience #startup in the #Boston-#Cambridge area looking for #labspace? Learn more about upcoming availability at Tufts Launchpad @biolabs, here in downtown Boston!

Check out our new brochure here: https://t.co/WE81QGSwtM
And apply here: https://t.co/rZUsbGRqBi

[Tufts Launchpad | BioLabs @BioLabsBoston]

Special thanks to our sponsor @NEBiolabs for sending us this wonderful assortment of breakfast and materials this morning!

[Tufts Launchpad | BioLabs @BioLabsBoston]

Congrats to Tufts Launchpad BioLabs resident company @PhagePro's CEO Dr. Minmin Yen for being recognized as a Woman Who Means Business by @BosBizJournal! Well deserved.

[PhagePro @PhagePro]

Congratulations to our CEO Dr. Minmin Yen for being selected as a Women Who Mean Business by @BosBizJournal! What a win for #GlobalHealth, for #PhageTherapy, and #WomenEntrepreneurs everywhere.

[LabCentral @LabCentral]

Exciting news! @BioLabs & @LabCentral have been chosen as the winner of the 2022 #PrixGalien USA Awards, in the “Incubators, Accelerators & Equity” category. It’s an honor to be recognized for our mission to create scientific spaces that fuel innovation.
https://t.co/whuUjW9FiO

[BioLabs @biolabs]

We were honored to receive the inaugural @GalienFdn award for "Incubators, Accelerators, and Equity". We share this milestone with all our partners, sponsors and startups who push the boundaries of #innovation every day!
https://t.co/4hvR7w0XGg

[Tufts Launchpad | BioLabs @BioLabsBoston]

We're #hiring! Join the Tufts Launchpad @biolabs team and support our early-stage biotech company residents as an Admin Ops / Sr. Admin Ops Associate.

Learn more and apply here: https://t.co/aiPZR8fJ8B

#administration #operations #biotech #administrative

[Tufts Launchpad | BioLabs @BioLabsBoston]

Congratulations and best of luck to Tufts Launchpad BioLabs' most recent graduate company @KalVista.

We will miss you, and thank you for the sweet treats!

[Tufts Launchpad | BioLabs @BioLabsBoston]

It was great hosting the team from @iCONM_BioLabs last week. Hopefully we'll get a chance to return the favor and visit them in #Kyoto soon, too!

[iCONM in collaboration with BioLabs @iCONM_BioLabs]

We visited Tufts Launchpad BioLabs (@BioLabsBoston)! This site is located on Tufts Medical Campus in downtown #Boston. It is very nice that the resident startups have access to Tufts University’s core facilities! #lifescience #startups #labspace

[Tufts Launchpad | BioLabs @BioLabsBoston]

We clearly have some very talented artists in residence here at Tufts Launchpad BioLabs!

Last week's TLB happy hour included a coloring break, complete with crayons, colored pencils, and science art. Lucky for us, some residents donated their art to decorate the café fridge!

[Tufts Launchpad | BioLabs @BioLabsBoston]

Are you a #lifescience #startup in the #Boston-#Cambridge area looking for #labspace? Learn more about upcoming availability at Tufts Launchpad @biolabs, here in downtown Boston!

Check out our new brochure here: https://t.co/WE81QGSwtM
And apply here: https://t.co/rZUsbGRqBi

[Tufts Launchpad | BioLabs @BioLabsBoston]

Congrats to Tufts Launchpad BioLabs graduate company @dermbiont on reaching this major milestone in their phase 2 #clinical trials of topical #drug candidate SM-020!

@biolabs #clinicaltrials #endpoint #biotech #lifescience #startup #graduate
https://t.co/um88e8mH8o

[Tufts Launchpad | BioLabs @BioLabsBoston]

Last week, the students of @EMLYON Business School and members of the French-American Chamber of Commerce, New England (@FACCNE) visited Tufts Launchpad BioLabs to learn more about @biolabs and our early-stage #lifescience resident companies.

#biotech #startups #entrepreneurship

[Hemerion Therapeutics @HemerionTx]

Look back at our recent immersion in Boston during March'22🇺🇸🇫🇷 👉🏼https://t.co/t6w1QO5nWs
Really fruitful meetings with inspiring people @MALifeSciences @Nanobiotix @treefrogtx @seabelife @CeresBrain @Diagnoly @BioLabsBoston @MassBio Thanks @Netva_fr and @FranceinBoston 🙏🏻

[Tufts Launchpad | BioLabs @BioLabsBoston]

Are you a #lifescience #startup in the #Boston-#Cambridge area looking for #labspace? Learn more about upcoming availability at Tufts Launchpad @biolabs, here in downtown Boston!

Check out our new brochure here: https://t.co/WE81QGSwtM
And apply here: https://t.co/rZUsbGRqBi

[Tufts Launchpad | BioLabs @BioLabsBoston]

@BioLabsBoston Gold sponsor @sanofi visited the site for a Meet & Greet with @biolabs residents to share their latest research & partnering strategies. We also celebrated recent @sanofi Golden Ticket winners and @BioLabsBoston residents Tenza 2020 and PeterBio 2022. Well done!

[ShapeTX @ShapeTx]

We joined @BioLabsBoston & @NMHS_TITANS for a session of the BioLabs' Biotech & Life Sciences Immersion Program. The program helps students learn from biotech leaders and better understand the many applications of a STEM education. We had a great time doing a hands-on experience!

[Tufts Launchpad | BioLabs @BioLabsBoston]

Big congratulations to alumni @elektrofi!

[Elektrofi @elektrofi]

Pleased to share that we've closed our $40M #SeriesB funding round enabling #pipeline and headcount growth. Excited for this next chapter https://t.co/QLVQgzWwBV
#biotech #drugdelivery #lifesciences #biologics #marshallwace #bvfpartners #janushenderson #logoscapital

[Tufts Launchpad | BioLabs @BioLabsBoston]

This week, Tufts Launchpad BioLabs hosted @BostonSchools for a #genetics-themed session of @biolabs #Biotech & #LifeSciences Immersion Program.

A special thanks to @BioLabsBoston resident @DropGenie for teaching us about their automated #gene editing technology! #DEI #STEM

[Danielle Bogdanowicz @D_R_Bogdanowicz]

Great day learning about #genetics and #geneediting technologies with @BostonSchools during yesterday’s session of @biolabs Biotech & Life Sciences Immersion Program. @BioLabsBoston

[Ovid Therapeutics @OvidRx]

Highlights from Q1 2022: Ovid anticipates filing IND for OV329 for #epilepsy & #seizures and plans to initiate Phase 1 trials in Q4 2022. We also expect to present preclinical data on OV329 at EILAT XVI and the @EpilepsyFdn Pipeline Conference. Read more: https://t.co/1hTSiVmAkk